Fulgent Genetics (FLGT) Income from Continuing Operations (2015 - 2026)
Fulgent Genetics (FLGT) posted Income from Continuing Operations of 29720000.0 for Q2 2026, down 17.59% sequentially from 25274000.0 in Q1 2026, and down 54.64% YoY from 65518316.13 in Q2 2025.
Fulgent Genetics (FLGT) Income from Continuing Operations (2015 - 2026) Analysis & Trends
Fulgent Genetics has reported Income from Continuing Operations for 12 years, with the latest figure at 29720000.0 in Q2 2026.
- Quarterly Income from Continuing Operations fell 54.64% year-over-year to 29720000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 79172000.0 (down 52.12% YoY) and the FY2025 annual result came in at 55320000.0, down 26.24% from the prior year.
- Income from Continuing Operations retreated to 29720000.0 in Q2 2026 per FLGT's latest filing, from 25274000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 153557000.0 in Q1 2022 and troughed at 122868000.0 in Q4 2023.
- A 5-year average of 9780555.56 and a median of 13656000.0 in 2023 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2023 and 2024: Income from Continuing Operations plunged 1102.68% in 2023, then soared 94.95% in 2024.
- Over 5 years, Income from Continuing Operations stood at 24076000.0 in 2022, then sank by 410.33% to 122868000.0 in 2023, then jumped by 94.95% to 6209000.0 in 2024, then slumped by 179.74% to 17369000.0 in 2025, then plunged by 71.11% to 29720000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 29720000.0, 25274000.0, and 17369000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -66.93 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 338.41 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 299.10 Mn |
| 10 | Fulgent Genetics | 557.44 Mn | 300.41 Mn | 25.68 Mn | -29.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -29.72 Mn |
| Mar 31, 2026 | -25.27 Mn |
| Dec 31, 2025 | -17.37 Mn |
| Sep 30, 2025 | -6.81 Mn |
| Jun 30, 2025 | -19.22 Mn |
| Mar 31, 2025 | -11.92 Mn |
| Dec 31, 2024 | -6.21 Mn |
| Sep 30, 2024 | -14.69 Mn |
| Jun 30, 2024 | -9.09 Mn |
| Mar 31, 2024 | -13.85 Mn |
| Dec 31, 2023 | -122.87 Mn |
| Sep 30, 2023 | -13.47 Mn |
| Jun 30, 2023 | -11.59 Mn |
| Mar 31, 2023 | -15.85 Mn |
| Dec 31, 2022 | -24.08 Mn |
| Sep 30, 2022 | 1.34 Mn |
| Jun 30, 2022 | 11.05 Mn |
| Mar 31, 2022 | 153.56 Mn |
| Dec 31, 2021 | 103.68 Mn |
| Sep 30, 2021 | 122.22 Mn |